Physician

Kristen Marie Pettit, M.D.

According to 2025 Medicare claims, Kristen Pettit, M.D. (NPI: 1518278365) practices hematology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF MICHIGAN (NPI: 1265758684; TIN: 386006309) and primary practice location at 48109-5000. Pettit is affiliated with the POM ACO (ACO ID: A1297), OSF Healthcare System (ACO ID: A3289), McLaren High Performance Network, LLC (ACO ID: A3317), Caravan Health ACO 43 LLC (ACO ID: A4974), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Pettit's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 168 traditional Medicare patients, billed 567 HCPCS/CPT codes, and received $34,834 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 974 prescription claims across 177 beneficiaries totaling $12,390,246 in drug costs, led by Jakafi (Ruxolitinib Phosphate). Open Payments data shows 40 records totaling $293,240. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $7,887 and ending at $34,834. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $203,932 to $12,390,246. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	33	94	$7,887
2018	106	451	$38,873
2019	117	503	$50,412
2020	140	530	$41,455
2021	130	354	$33,472
2022	172	502	$43,534
2023	160	358	$30,843
2024	168	567	$34,834

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	29	99	$203,932
2016	42	264	$249,250
2017	24	175	$198,039
2018	42	150	$366,971
2019	51	208	$1,171,298
2020	69	394	$2,256,336
2021	80	485	$3,401,944
2022	120	649	$4,229,723
2023	140	803	$6,533,840
2024	177	974	$12,390,246

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	25	25	$127
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	54	97	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	114	168	$69
99443	Telephone medical discussion with physician, 21-30 minutes	22	24	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	111	174	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	220	6,500	$3,479,930
Ayvakit	Avapritinib	73	2,190	$3,048,452
Ojjaara	Momelotinib Dihydrochloride	98	2,929	$2,640,725
Xospata	Gilteritinib Fumarate	16	480	$449,034
Idhifa	Enasidenib Mesylate	12	360	$388,155

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$18,196	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	33	$275,044	Univ Of Mi Hospitals & Hlth Ctrs
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kristen Marie Pettit, M.D.?

Tedicare shows public-source Medicare data for Kristen Marie Pettit, M.D. (NPI 1518278365), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kristen Marie Pettit, M.D. have ACO affiliation data?

Kristen Marie Pettit, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), OSF Healthcare System (MSSP, ACO ID A3289), McLaren High Performance Network, LLC (MSSP, ACO ID A3317), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Kristen Marie Pettit, M.D.?

Kristen Marie Pettit, M.D. is linked to REGENTS OF THE UNIVERSITY OF MICHIGAN (billing NPI 1265758684) in the available physician profile data.

Does Kristen Marie Pettit, M.D. have Open Payments data?

Kristen Marie Pettit, M.D. has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.